Evidence map›Paper›PMID 34201733›Full record

ReviewInternational journal of molecular sciences2021

Emerging Prospects for Combating Fungal Infections by Targeting Phosphatidylinositol Transfer Proteins.

Danish Khan, Aaron H Nile, Ashutosh Tripathi, Vytas A Bankaitis

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Regulation of yeast polarized exocytosis by phosphoinositide lipids.Cellular and molecular life sciences : CMLS · 2024
    Review
  5. Regulation of phosphoinositide metabolism in Apicomplexan parasites.Frontiers in cell and developmental biology · 2023
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Danish KhanDepartment of Biochemistry & Biophysics, Texas A&M University, College Station, TX 77843-2128, USA.
Aaron H NileCalico Life Sciences LLC, 1170 Veterans Blvd, South San Francisco, CA 94080, USA.ORCID 0000-0002-7370-8769
Ashutosh TripathiDepartment of Molecular & Cellular Medicine, Texas A&M Health Sciences Center, College Station, TX 77843-1114, USA.
Vytas A BankaitisDepartment of Biochemistry & Biophysics, Texas A&M University, College Station, TX 77843-2128, USA.
Texas A&M Health Science Center · USEnzo Life Sciences (United States) · USTexas A&M University · US

Funding

The Biology and Biochemistry of Lipid Transfer Protein-Regulated Phosphoinositide SignalingR35GM131804 · NIGMS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI Vytas A Bankaitis · 2019 to 2026
$4.5M
NIGMS NIH HHS R35 GM131804
6 · The paper itself

Abstract

The emergence of fungal "superbugs" resistant to the limited cohort of anti-fungal agents available to clinicians is eroding our ability to effectively treat infections by these virulent pathogens. As the threat of fungal infection is escalating worldwide, this dwindling response capacity is fueling concerns of impending global health emergencies. These developments underscore the urgent need for new classes of anti-fungal drugs and, therefore, the identification of new targets. Phosphoinositide signaling does not immediately appear to offer attractive targets due to its evolutionary conservation across the Eukaryota. However, recent evidence argues otherwise. Herein, we discuss the evidence identifying Sec14-like phosphatidylinositol transfer proteins (PITPs) as unexplored portals through which phosphoinositide signaling in virulent fungi can be chemically disrupted with exquisite selectivity. Recent identification of lead compounds that target fungal Sec14 proteins, derived from several distinct chemical scaffolds, reveals exciting inroads into the rational design of next generation Sec14 inhibitors. Development of appropriately refined next generation Sec14-directed inhibitors promises to expand the chemical weaponry available for deployment in the shifting field of engagement between fungal pathogens and their human hosts.

Indexed as

AnimalsAntifungal AgentsHumansMycosesPhospholipid Transfer ProteinsAntifungal AgentsPhospholipid Transfer Proteinsantifungal drugscandidiasischemical geneticsdrug-resistant fungiphosphoinositides

Identifiers

PMID34201733
PMCPMC8269425
OpenAlexW3175262616

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.